Nivolumab vs Phenytoin
Nivolumab vs Phenytoin: Overview
This comparison examines the pharmacological differences between Nivolumab and Phenytoin.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Phenytoin: Sodium channel blocker stabilizing inactive state.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Phenytoin β 22 hours.
Chemical Properties
Molecular Formula: Phenytoin β C15H12N2O2.
Molecular Weight: Phenytoin β 252.2680 g/mol.
Type: Nivolumab β Antibody; Phenytoin β Small molecule.